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Abstract In the present study, we tested whether elderly
with a high dietary intake of eicosapentaenoic acid
(EPA) and docosahexaenoic acid (DHA) would have
higher cognitive test scores and greater brain volume
than those with low dietary intake of these fatty acids.
Data were obtained from the Prospective Investigation of
the Vasculature in Uppsala Seniors (PIVUS) cohort. The
dietary intake of EPA and DHAwas determined by a 7-
day food protocol in 252 cognitively healthy elderly (122
females) at the age of 70 years. At age 75, participants'
global cognitive function was examined, and their brain
volumes were measured by magnetic resonance imaging
(MRI). Three different multivariate linear regression
models were applied to test our hypothesis: model A
(adjusted for gender and age), model B (additionally
controlled for lifestyle factors, e.g., education), and mod-
el C (further controlled for cardiometabolic factors, e.g.,
systolic blood pressure). We found that the self-reported
7-day dietary intake of EPA and DHA at the age of
70 years was positively associated with global gray
matter volume (P<0.05, except for model C) and in-
creased global cognitive performance score (P<0.05).
However, no significant associations were observed be-
tween the dietary intake of EPA and DHA and global
white matter, total brain volume, and regional gray mat-
ter, respectively. Further, no effects were observed when
examining cognitively impaired (n027) elderly as sepa-
rate analyses. These cross-sectional findings suggest that
dietary intake of EPA and DHA may be linked to im-
proved cognitive health in late life butmust be confirmed
in patient studies.
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Introduction
Eicosapentaenoic acid (EPA, 20:5n-3) and docosahex-
aenoic acid (DHA, 22:6n-3), also known as omega-3
fatty acids, are polyunsaturated fatty acids that are
mainly found in fish and food of marine origin. In
humans, these fatty acids can be produced by enzy-
matic elongation and desaturation of their precursor α-
linolenic acid (ALA, C18:3n-3). However, this con-
version is very inefficient (Burdge 2004). Bearing in
mind that EPA and DHA form major structural lipid
components of neural membranes in the central ner-
vous system (CNS) (Kawakita et al. 2006), a low
intake of these omega-3 polyunsaturated fatty acids
may contribute to cognitive aging in elderly.
Supporting this view, epidemiological data have dem-
onstrated that reduced dietary intake of EPA and DHA
is associated with accelerated cognitive decline or the
development of dementia, including Alzheimer's dis-
ease (Kalmijn et al. 1997, 2004), (van Gelder et al.
2007), (Samieri et al. 2008), (Huang 2010), (Dangour
et al. 2010), (Cederholm and Palmblad 2010). These
findings support the view that a high dietary intake of
EPA and DHA during late adulthood could serve as a
promising public health intervention to counteract
cognitive decline facing aging modern societies.
However, there are also negative findings demonstrat-
ing that the dietary intake of omega-3 fatty acids does
not affect the rate of cognitive decline and the risk to
develop dementia among elderly (Engelhart et al.
2002), (Devore et al. 2009). For instance, in the
Rotterdam Study which initially included 5,395 par-
ticipants (age, ≥55 years) who were free of dementia, a
follow-up investigation ten years later revealed that
the dietary intake of omega-3 fatty acids did not ap-
pear to be associated with long-term dementia risk
(Devore et al. 2009). A potential drawback of many
studies that also warrants attention is the inclusion of
participants with heterogeneous age.
Against this background, the present community-
based epidemiological study with a large cohort
addressed the hypothesis that a high dietary intake of
EPA and DHA in men and women at the age of 70 years
was associated with both greater brain volume and
better cognitive performance. To this aim, the daily
intake of EPA and DHA was determined by means of
a 7-day food protocol at the age of 70 years. To add
further support to self-report measures of food intake,
the plasma fatty acid composition was also determined.
Factors that are known to affect cognitive performance
and brain structure in the general population (education,
self-reported physical activity, serum concentration of
low-density cholesterol, body mass index, systolic
blood pressure, and insulin resistance were measured
at the age of 70 years so that they could be included as
covariates. Five years after the dietary records were
obtained, all participants underwent a magnetic reso-
nance imaging (MRI) brain scan. Further, as a test of
general cognitive function, the 7-min screen (7MS) test
was administered (Solomon et al. 1998).
Subjects and methods
Design
The study is based on the prospective cohort study
“Prospective Investigation of the Vasculature in
Uppsala Seniors” (PIVUS) (Lind et al. 2005), that
initially included 1,016 (50 % females) individuals
aged 70 living in the community of Uppsala,
Sweden. The primary study aim was to investigate
endothelial function and arterial compliance in a ran-
dom sample of elderly subjects. After their inclusion
between 2001 and 2003 during which a 7-day food
diary was obtained, 827 subjects from the initial co-
hort agreed to participate in a follow-up investigation
5 years later (81.4 % response rate), i.e., when they
were 75 years old. Of the individuals who were re-
investigated at the age of 75 years, a subsample of 409
elderly agreed to participate in a magnetic resonance
imaging (MRI) scan of their brains (49.5 % of the
cohort that was re-investigated at the age of 75 years).
Of this number, 252 elderly satisfied all criteria for this
study, including cognitively normal clinical status
(identified by an MMSE score greater than 26)
(Folstein et al. 1975), absence of strokes or neurologic
diseases (e.g., tumors) at ages 70 and 75, valid meas-
ures from the MRI brain scan, and an availability of
the food diary record at the age of 70 years (Flow-
chart, please see Fig. 1). Exclusions were administered
to minimize the confounding effects of variables relat-
ed to our main question: does the dietary intake of
DHA and EPA at the age of 70 years relate to cogni-
tion and brain structure 5 years later among cognitive-
ly healthy elderly. In addition, a subpopulation (n0
198) was created in which individuals with unreliable
dietary records were excluded (see below).
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The study was approved by the Ethics Committee
of the University of Uppsala and the participants gave
informed consent to participate.
Dietary assessment
Dietary habits were determined as previously pub-
lished (Sjogren et al. 2010). Briefly, the participants
were given oral instructions by a dietitian on how to
perform the dietary registration over seven consecu-
tive days, and the amounts consumed were reported in
household measurements or specified as portion sizes.
The daily intake of EPA and DHA was calculated by
using a database from the Swedish National Food
Agency containing about 1,500 food items, drinks,
and recipes. Non-adequate reporters of energy intake
were identified using the Goldberg cutoff (Black
2000) taking the level of physical activity and basal
metabolic rate into consideration.
Assessments of physical activity and education
at the age of 70 years
Physical activity (PA) was divided into light and hard
exercise and classified as number of activities with a
duration of at least 30 min per week. The participants
were asked how many times per week they performed
light (e.g., walking, gardening), respectively hard ex-
ercise (e.g. running, swimming) for at least 30 min.
Based on the responses to these questions, four PA
categories were constructed: very low, low, medium,
and high.
Fig. 1 Subject inclusionary
criteria and sample sizes
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The educational level (i.e., primary school, second-
ary school, and university level) for each subject was
assessed by means of a standardized questionnaire.
Clinical and biochemical investigation at the age
of 70 years
Blood samples were collected in the morning after an
overnight fast using Architect (Abbott, Abbot Park, IL,
USA) for biochemical analysis, unless otherwise stated.
Low-density lipoprotein (LDL) cholesterol was calculat-
ed using Friedewald's formula. Plasma glucose and se-
rum insulin concentration values were used to calculate
the homeostasis model assessment-insulin resistance
(HOMA-IR; [(fasting plasma glucose×fasting serum in-
sulin)/22.5]), a measure of insulin sensitivity (Wallace
and Matthews 2002). The proportion of DHA and EPA
in serum phospholipids was measured as previously
described (Warensjo et al. 2009). Briefly, the samples
were extracted in chloroform, separated by thin-layer -
chromatography, trans-methylated and then separated by
gas liquid chromatography with a system from Hewlett-
Packard (Avondale, PA)) on a capillary column
(Quadrex, New Heaven, CT, USA). Methyl ester stand-
ards (GLC- 68A, Nu Check Prep, Elysian, MN, USA)
were used to identify the DHA and EPA. After recording
height and weight allowing the calculation of the body
mass index (BMI, kilogram per square meter), the sub-
jects were supine in a quiet room maintained at a con-
stant temperature, and the systolic blood pressure (BP)
was measured by a calibrated mercury sphygmomanom-
eter in the non-cannulated arm to the nearest mmHg.
Cognitive measures
At the age of 75 years, a Swedish translation of the
7 min screen (7MS) test was administered to the
participants by trained study nurses. This test is clin-
ically used to screen for dementia and cognitive de-
cline, and has been described in (Solomon et al. 1998).
The 7MS consists of four brief cognitive tests:
Benton temporal orientation—BTO (Benton
1983): In this test, the orientation for time is
measured and quantified in terms of degree of
error. The maximum score is 113 (10 error points
for one year, 5 points for one month, 1 for the date
and the day of a week, and 1 for each 30 min
deviation in time).
Enhanced cued recall—ECR (Grober et al. 1988):
This declarative memory test requires the subject
to recall 16 figures. The score is the total number
of items recalled in both free and cued recall
(range, 0–16).
Clock drawing—CD (Freedman et al. 1994): This
test is to examine the visuoconstruction. In detail,
the subject has to draw the face of a clock and
place the hands of the clock at a given time. The
maximum score is 7 points.
Categorical verbal fluency—VF: In this semantic
test, the subject has to name as many different
animals as possible in 1 min time.
The raw scores of the four subtests of the 7MS were
summed with the logistic regression formula described
previously (Solomon et al. 1998): Ln P= 1 Pð Þ½  ¼
35:59 1:303  ECR 1:378  VFþ 3:298  BTO
0:838  CD, where P is the probability of having de-
mentia. Solomon estimated the formula by using the
scores of the four tests from the screening battery as
predictor variables. The natural logarithm (ln) of
P/(1−P) is equal to the total 7MS score of the above
logistic regression formula. The more negative the
total raw score on the 7-min screening (7MS) test,
the lower the probability of having dementia (3). For
purposes of presentation, scores were inverted, such
that the higher the score the better the performance on
the 7MS.
MRI acquisition and processing
At the age of 75 years, regional measures of brain
volume were acquired with MRI. A high resolution
3D T1-weighted volumetric “Turbo Field Echo” (TFE)
scan was acquired using a Philips 1.5 Tesla scanner
(Gyroscan NT, Philips Medical Systems, Best, The
Netherlands). The 3D gradient echo sequence was ac-
quired with the scan parameters TR 8.6 ms, TE 4.0 ms,
flip angle08°. Sagittal slices with a field of view of
240 mm, a slice thickness of 1.2 mm, and an in-slice
resolution of 0.94 mm2 were reconstructed.
Images were processed using Voxel Based
Morphometry (VBM), a technique that used statistical
parametric mapping (SPM) to determine local concen-
trations of gray matter volumes on a voxel-by-voxel
basis (Ashburner and Friston 2000). Gray matter was
calculated by segmenting it from white matter and
cerebrospinal fluid using the unified segmentation
1498 AGE (2013) 35:1495–1505
approach (Ashburner and Friston 2005). Following this
segmentation procedure, probability maps of gray mat-
ter were “modulated” to account for the effect of spatial
normalization, by multiplying the probability value of
each voxel by its relative volume in native space before
and after warping. Gray matter images based on proba-
bility maps at each voxel were normalized intoMontreal
Neurological Institute (MNI) standard space with a
voxel size of 2×2×2 mm. Modulated images were
smoothed with an 8-mm Full Width Half Maximum
(FWHM) Gaussian kernel, in line with other recent
VBM studies (Walther et al. 2010). This smoothing
kernel was applied prior to statistical analysis, to reduce
signal noise and to correct for image variability. VBM
analyses were carried out using SPM8 (Functional
Imaging Laboratory, University College London)
(Ashburner and Friston 2000).
Statistical analysis
For statistical evaluation, SPSS version 19.0 (SPSS
Inc, Chicago, IL) was used. Data are presented as
means±SEMs and were analyzed using linear regres-
sion models. Normal distribution of all variables was
confirmed by Kolmogorov–Smirnov (KS) testing.
Since the 7-day food record approximates does not
exactly correspond to the actual intake of EPA and
DHA, the participants were divided into four groups
according to their daily intake of EPA and DHA: very
low (0.026–0.226 g; <25th percentile), low (0.228–
0.387 g; 25th–50th percentile), medium (0.40–
0.666 g; 50th–75th percentile), and high intake
(0.667–1.910 g; >75th percentile). Gray matter, white
matter, and total brain volumes are expressed as rela-
tive to the total intracranial volume (TIV). To test our
hypothesis that the dietary intake of EPA and DHA is
linked to greater brain volume and better cognitive
performance, three linear regression models were ad-
ministered, covarying for factors that have been pre-
viously described to be associated with our main
measures in the general population:
Model A: adjusting for gender and exact age
Model B: model A+energy intake, education (Le
Carret et al. 2003), and self-reported
physical activity (Weuve et al. 2004)
Model C: model B+serum concentration of low-
density cholesterol (Ward et al. 2010),
BMI (Brooks et al. 2012), systolic blood
pressure (Muller et al. 2010) and HOMA-
IR (Benedict et al. 2012).
The three models were applied in our main study
population as well as in the subpopulation of adequate
reporters of energy intake.
In addition to global brain measures (i.e., gray
matter, white matter, and total brain tissue), a voxel-
based morphometry regression model was tested to
examine as to whether the EPA and DHA intake is
predictive for regional gray matter volumes, control-
ling for both gender and total intracranial volume
(TIV, defined as the sum of gray matter, white matter,
and cerebrospinal fluid). All clusters and peak voxels
of gray matter T statistic brain maps reported were
thresholded at a P value<0.05 by using Family Wise
Error (FWE). In order to avoid possible edge effects
between different tissue types, we excluded from our
analyses all voxels with gray matter probabilities of
less than 0.1 (absolute threshold masking). The asso-
ciation between the DHA and EPA content in serum
phopholipids and dietary intake of these fatty acids
was specified by Spearman's rank test. Overall, a two-
sided P value less than 0.05 was considered
significant.
Results
Self-reported 7-day EPA and DHA intake is positively
linked to gray matter volume and cognitive
performance
Descriptive data of the study population are shown in
Table 1. The basic linear regression model in the prima-
ry analysis revealed a positive association between the
dietary intake of EPA and DHA at the age of 70 years
and global gray matter volume five years later (Table 2).
Subsequent regression model controlling for lifestyle
factors (all measured at the age of 70 years) confirmed
this significant association (Table 2). In the regression
model C, further controlled for cardiometabolic con-
founders, the dietary intake of EPA and DHA was still
positively linked to global gray matter volume.
However, this association failed to reach the 5 % signif-
icance level (Table 2). In contrast, regression analysis
did not produce any significant associations between the
dietary intake of EPA and DHA on the one side and
white matter volume and total matter volume on the
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other side (Table 2). Using whole-brain correction for
multiple comparisons, voxel-based morphometry did
not produce any regional differences in gray matter.
Despite its association with global gray matter, the die-
tary intake of EPA and DHAwas also positively linked
to the 7MS score (i.e., the total score obtained on four
cognitive subtests). This association remained signifi-
cant in all models (Table 2).
Importantly, similar but slightly less significant
functional and structural results were obtained when
excluding 54 participants from the analyses who ap-
parently did not report their dietary intake properly
(Table 3).
For all analyses presented, the interaction term of the
dietary intake of EPA and DHA by gender did not reach
significance. Regarding the cognitively impaired sub-
group (n027), separate regression analyses revealed no
significant association between the dietary intake of EPA
and DHA on the one hand and cognitive functions and
brain structure on the other hand (data are not shown).
Correlation between DHA and EPA intake
and their proportion in serum phospholipids
Correlational analyses revealed that the estimated dai-
ly dietary intake of EPA and DHA was positively
Table 1 Descriptive statistics of participants, stratified according to their daily intake of eicosapentaenoic and docosahexaenoic acids
EPA/DHA intake
Very low Low Medium High
No. of subjects 63 63 63 63
No. of females 25 31 34 32
Educational level (primary/secondary
school/university; n/n/n)
32/13/18 40/13/10 35/11/17 29/12/22
At 70 years
Exact age 70.1±0.0 70.2±0.0 70.2±0.0 70.1±0.0
Intake of EPA/DHA (g/day) 0.13±0.01 0.30±0.01 0.52±0.01 0.98±0.03
Range of EPA/DHA intake (g/day) 0.026–0.226 0.228–0.387 0.400–0.666 0.667–1.910
Energy intake, KJ 8057±333 7665±236 8076±254 8230±271
BMI, in kg/m2 26.7±0.5 26.0±0.4 26.4±0.5 26.7±0.4
Blood glucose levels, in mmol/L (A) 4.95±0.07 4.88±0.05 4.83±0.06 4.90±0.06
Blood insulin levels, in μg/dL (B) 7.92±0.52 8.58±0.54 7.87±0.78 7.65±0.56
HOMA-IR (A*B/22.5) 1.77±0.13 1.87±0.12 1.57±0.10 1.68±0.13
Serum LDL cholesterol, in mmol/L 3.47±0.13 3.41±0.09 3.55±0.09 3.55±0.11
Systolic blood pressure, in mmHg 145±3 144±2 149±3 146±2
Self-reported Physical activity (four levels) 2.32±0.10 2.29±0.09 2.31±0.10 2.28±0.08
At 75 years
Exact age 75.2±0.0 75.3±0.0 75.3±0.0 75.3±0.0
Gray matter volume, ml 574±8 571±9 565±8 585±7
White matter volume, ml 456±6 438±8 443±8 447±7
TIV, ml 1772±16 1744±19 1706±20 1762±19
MMSE (max score 30) 29.0±0.1 28.8±0.1 29.1±0.1 29.1±0.1
Benton temporal orientation 0.46±0.19 0.54±0.18 0.32±0.07 0.38±0.12
Enhanced cued recall (max score 16) 15.75±0.09 15.68±0.11 15.78±0.07 15.87±0.04
Clock drawing (max score 7) 6.4±0.1 6.4±0.1 6.5±0.1 6.5±0.1
Verbal fluency (words per min) 19.9±0.7 20.1±0.7 20.2±0.6 21.9±0.6
If not otherwise described, raw data are mean±SEM. Abbreviations: BMI, body mass index; DHA, docosahexaenoic acid; EPA,
eicosapentaenoic acid; HOMA-IR, homeostasis model assessment (Wallace and Matthews 2002); LDL, low-density lipoprotein
cholesterol; MMSE, mini-mental state examination (Folstein et al. 1975); TIV, total intracranial volume (i.e., the sum of gray matter,
white matter, and cerebrospinal fluid)
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associated with the proportion of these fatty acids in
circulating phospholipids at the age of 70 years
(Spearman's r00.400, p<0.0001; Fig. 2). The
corresponding association in the subpopulation of on-
ly adequate reporters did also reach significance
(Spearman's r00.362, p<0.0001). There were no asso-
ciations between plasma EPA or DHAwith the perfor-
mance on the 7MS or brain volume estimates.
Discussion
Using data obtained from a large, community-based
cohort of elderly Swedish men and women, we present
a novel positive association between the dietary intake of
EPA, DHA, brain function, and structure. Specifically,
those whose diets were rich in EPA and DHA at the age
of 70 years obtained significantly higher total scores on
four standardized cognitive tests, and had significantly
greater gray matter volumes 5 years later, than those
whose diets were low in these fatty acids. Importantly,
correlation analyses revealed that the estimated daily
dietary intake of EPA and DHAwas positively associat-
ed with the proportion of these fatty acids in circulating
phospholipids, suggesting that the 7-days food record
was a valid measure to approximate the habitual intake
of EPA and DHA in our elderly sample. However, there
was no significant relationship between plasma propor-
tions of these fatty acids and cognitive tests or gray
matter volumes, perhaps due to peripheral mechanisms
Table 2 The association between the daily intake of eicosapentaenoic and docosahexaenoic acid at the age of 70 years and cognitive















32.4±0.3 32.7±0.4 33.1±0.4 33.3±0.4 Model A 0.14 0.03 0.06
Model B 0.12 <0.05 0.07




25.7±0.3 25.1±0.3 25.9±0.3 25.3±0.2 Model A −0.01 0.93 0.02
Model B −0.02 0.74 0.05




58.1±0.5 57.8±0.6 59.1±0.5 58.6±0.5 Model A 0.10 0.12 0.07
Model B 0.08 0.20 0.09
Model C 0.07 0.29 0.12
7MS (total score),
75 years
16.1±1.1 16.1±1.2 17.2±0.9 19.5±1.0 Model A 0.15 0.02 0.03
Model B 0.14 0.02 0.16
Model C 0.13 0.03 0.23
Raw data are mean±SEM. To test our hypothesis that the dietary intake of eicosapentaenoic and docosahexaenoic acid (EPA and DHA,
respectively) at the age of 70 years is linked to greater brain volume (measured by magnetic resonance imaging and analyzed by voxel-
based morphometry, (Ashburner and Friston 2000)) and better cognitive performance (7-min screening, 7MS; (Solomon et al. 1998))
5 years later. The following linear regression models were administered: Model A, adjusting for gender, age; Model B, controlling for
gender, age, energy intake, education (Le Carret et al. 2003), and self-reported physical activity (Weuve et al. 2004); Model C,
covarying for gender, age, energy intake, education, self-reported physical activity, serum concentration of low-density cholesterol
(Ward et al. 2010), BMI (Brooks et al. 2012), systolic blood pressure (Muller et al. 2010) and HOMA-IR (Benedict et al. 2012). To
control for individual differences in head size, the regression models testing brain volumes were additionally controlled for total
intracranial volume (TIV, defined as the sum of gray matter, white matter, and cerebrospinal fluid). Note that brain tissue equals the sum
of white matter and gray matter. Overall, a p value less than 0.05 was considered significant (significances are indicated in bold). The ƒ2
effect size measure was defined as: ƒ2 0R2 /(1−R2 ). By convention, ƒ2 effect sizes of 0.02, 0.15, and 0.35 are termed small, medium,
and large, respectively (Cohen 1988)
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Table 3 The association between the daily intake of eicosapentaenoic and docosahexaenoic acid at the age of 70 years and cognitive















32.6±0.4 32.7±0.4 33.5±0.4 33.5±0.4 Model A 0.14 <0.05 0.08
Model B 0.14 0.04 0.10




25.7±0.3 25.2±0.4 26.2±0.3 25.2±0.2 Model A −0.01 0.85 0.02
Model B −0.02 0.83 0.05




58.3±0.6 57.9±0.6 59.7±0.6 58.7±0.5 Model A 0.09 0.18 0.08
Model B 0.10 0.16 0.12
Model C 0.09 0.20 0.14
7MS (total score),
75 years
16.5±1.3 15.9±1.3 18.3±0.9 19.3±1.2 Model A 0.14 <0.05 0.02
Model B 0.12 0.07 0.16
Model C 0.12 0.08 0.22
Raw data are mean±SEM. Overall, a p value less than 0.05 was considered significant (significances are indicated in bold). For a
detailed description, please see legend of Table 2
Fig. 2 Positive correlation
between daily intake of
eicosapentaenoic and doco-
sahexaenoic acids and their
proportion in serum phos-
pholipids. Correlational
analyses between the esti-
mated daily dietary intake of
eicosapentaenoic acid (EPA)
and docosahexaenoic acid
(DHA) and the proportion of
these fatty acids in circulat-
ing phospholipids (PL) at
the age of 70 years. Spear-
man's rho00.40, P<0.05;
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that cause varied fluctuations in blood, and thus high-
lighting that some caution must be heeded when inter-
preting the results in brain. Further studies will be needed
to establish and further elucidate whether consumption
of omega-3 polyunsaturated fatty acids may have subtle
but positive effects on both brain function and structure.
Findings from this study are in line with previous
epidemiological studies. For instance, both high fish
consumption and dietary intake of EPA and DHA have
been shown to postpone cognitive decline in cogni-
tively healthy elderly (van Gelder et al. 2007),
(Kalmijn et al. 2004) (Albanese et al. 2009). In addi-
tion, previous interventional studies have revealed that
DHA supplementation may improve learning and
memory function in cognitively healthy elderly
(Yurko-Mauro et al. 2010). Providing further evidence
for a beneficial effect of omega-3 fatty acids on cog-
nitive aging, a recent DHA intervention study over
6 months has indicated possible retardation of cogni-
tive decline in patients with mild Alzheimer's disease
(Freund-Levi et al. 2006). These studies, together with
findings that both high plasma concentration of EPA
and habitual high consumption of fish are associated
with lower incidence of late-life dementia (Samieri et
al. 2008), have received a recent increase in research
focus. Nevertheless, the reader should bear in mind
that other studies have not found beneficial effects of
omega-3 fatty acids on mental health. For instance, in
a randomized, double-blind, placebo-controlled trial
including 302 individuals aged > or 065 years, EPA/
DHA supplementation for 26 weeks did not improve
mental well-being (van de Rest et al. 2008). Further,
an 18-month supplementation with DHA compared
with placebo failed to slow the rate of cognitive and
functional decline in a total of 402 patients with mild
to moderate Alzheimer's disease (Quinn et al. 2010).
These contrasting data do not stand against a support-
ing role of EPA and DHA for mental health in elderly,
whereas they raise questions regarding the therapeutic
potential of consuming omega-3 fatty acids to deter
the cognitive decline in those suffering from moderate
to severe AD (Cederholm and Palmblad 2010).
The cross-sectional nature of our study precludes
any assumption about the cause and effect relationship
between variables. However, there are data offering
mechanisms by which the intake of omega-3 fatty
acids potentially benefits functional and structural brain
health in late life. For instance, omega-3 fatty acids have
anti-inflammatory and vasodilatory properties (Holub
and Holub 2004), which may protect general vascular
health, and as a secondary effect, maintain blood perfu-
sion of the brain in those whose diets are rich in EPA and
DHA. Recently, another mechanism that has gained
attention is the finding that DHA, once circulating in
the CNS, is available for conversion to neuroprotectin
D1 (Bazan et al. 2011). NPD1 elicits neuroprotec-
tion in brain (Mukherjee et al. 2004), and, inter-
estingly, has been shown to be deficient in AD brains
(Lukiw et al. 2005).
Limitations
In contrast to the significant association that was ob-
served between the dietary intake of EPA and DHA
and the performance on the 7MS (i.e., the cognitive
test applied here) and global gray matter, respectively,
we did not find such an association when considering
plasma proportions of EPA and DHA as an indepen-
dent variable. One explanation might be that there is
likely to be inter-individual fluctuations in circulating
concentrations of these fatty acids, which means that
there is a potential mismatch between the proportion
of these fatty acids in phospholipids and their plasma
blood levels. Another limitation is that this study does
not detail whether dietary intake of EPA and DHA
promotes brain health; it only describes an association
between the two characteristics. The reader should
also bear in mind that the associations between the
dietary intake of EPA and DHA and brain health
obtained in the primary study population (i.e., in 252
elderly) included a subsample of subjects who, based
on the Goldberg equation (Black 2000), apparently did
not report their dietary intake properly. This may po-
tentially have confounded our main results. However,
although weaker regarding its significance, the same
associations were demonstrated after exclusions of
non-adequate reporters (i.e., in 198 elderly). This sug-
gests that the inclusion of this subsample is unlikely to
bias our main results. Further, the reader should con-
sider that there was an interval of 5 years between the
assessment of dietary intake of EPA and DHA and the
7MS and brain volume measurements. As a result, no
definite conclusions can be drawn as to whether the
participants followed a similar dietary pattern at the
age of 75 years, as they did at the age of 70 years.
Finally, confounds by other factors not considered in
the present study cannot be excluded.
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Conclusions
Our results provide a potential link between con-
sumption of diets rich in EPA and DHA and en-
hanced mental health in the elderly. However, this
preliminary finding warrants further randomized
prospective trials, including repeated measures of
cognitive function and brain structure in both cog-
nitively healthy elderly and patients with cognitive
impairment. Interestingly, EPA and DHA are mainly
found in fish and food of marine origin, which
constitutes an important part of the Mediterranean
diet (Sjogren et al. 2010). Thus, it cannot be ruled
out that the positive association between the dietary
intake of EPA and DHA and brain health observed
in our elderly study population is driven by the
adherence to an healthy lifestyle, rather than by
these nutritional factors alone. Further, when evalu-
ating the positive association between omega-3 fatty
acid intake and brain measures, it must be born in
mind that the beneficial effects are relatively small,
as compared to those related to other lifestyle fac-
tors, such as education (Le Carret et al. 2003) and
physical activity (Weuve et al. 2004). We did not
find any association between the dietary intake of
EPA and DHA, cognitive function, and brain struc-
ture in the cognitively impaired subgroups. Thus,
the reader must be careful in making assumptions
about the influence of the dietary intake of EPA
and DHA on cognitive performance and brain struc-
ture in cognitively impaired patients.
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